The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors
Date
2011Author
Gringeri, A.
Lassila, R.
Morfini, M.
Negrier, C.
Rocino, A.
Schramm, W.
Serban, M.
Uscatescu, M. V.
Windyga, J.
Leissinger, C.
Zulfikar, B.
Antmen, B.
Berntorp, E.
Biasioli, C.
Carpenter, S.
Kavakli, K.
Metadata
Show full item recordCollections
- Makale [92796]